NCT00832455View on ClinicalTrials.gov

Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

PHASE4CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Asthma
Interventions
DRUG

montelukast sodium

Montelukast 4-5 mg for 12 weeks, oral tablet

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00832455 - Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385) | Biotech Hunter | Biotech Hunter